| Emily N Gardenhire, OTD, OTR/L | |
|
1595 S Calumet Rd Ste 3, Chesterton, IN 46304-2389 | |
| (219) 764-4888 | |
| (199) 894-2582 |
| Full Name | Emily N Gardenhire |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1595 S Calumet Rd Ste 3, Chesterton, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336747740 | NPI | - | NPPES |
| 200196020A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 31006927A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily N Gardenhire, OTD, OTR/L Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Emily N Gardenhire, OTD, OTR/L 1595 S Calumet Rd Ste 3, Chesterton, IN 46304-2389 Ph: (219) 764-4888 |
News Archive
Refugee children have scant access to medical care and are particularly vulnerable to disease. Fresh research results from the University of Copenhagen show that just a few hours of schooling a week may have a pronounced positive impact on their health not only in childhood but later in life when they achieve adulthood.
A new study published in the journal Nature in April 2020 reports on a malaria protein antibody that appears to protect resistant children from severe disease, showing promise in the fight against malaria, a new study found. Almost 500,000 people die of malaria every year.
The American research consortium Type 1 Diabetes TrialNet presented their results of a Phase II study with the antigen-based diabetes therapy Diamyd yesterday, June 27, at the American Diabetes Association 71st Scientific Sessions (ADA) in San Diego, California, USA, after the closing of the stock market.
A new study published on the preprint server medRxiv in May 2020 shows that while the virus causing COVID-19 may be present in wastewater and rivers, the biological agent is typically devoid of vitality and unable to cause active infection. This should provide some relief to public health authorities in their quest to contain the virus.
The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
› Verified 1 days ago
Mrs. Michelle Louise Kirkham, MHS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1131 Olivia Ct, Chesterton, IN 46304 Phone: 219-771-9150 | |
Tara Lehmann, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1595 S Calumet Rd Ste 3, Chesterton, IN 46304 Phone: 219-764-4888 | |
Erin Crews, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1595 S Calumet Rd Ste 3, Chesterton, IN 46304 Phone: 219-764-4888 Fax: 219-898-4258 | |
Kathleen Miller, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1120 S Calumet Rd Ste 3, Chesterton, IN 46304 Phone: 219-983-9675 Fax: 219-983-9681 | |
Mrs. Stefanie Breanne Whalen, COTA/ T OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1348 Dixon Pkwy, Chesterton, IN 46304 Phone: 219-707-6511 | |
Molly Shannon, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1120 S Calumet Rd Ste 3, Chesterton, IN 46304 Phone: 219-983-9675 Fax: 219-983-9681 | |
Linda Ronjak, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Beverly Dr, Chesterton, IN 46304 Phone: 219-926-8387 Fax: 847-441-0734 |